Avantax Planning Partners, Inc. Hcw Biologics Inc. Transaction History
Avantax Planning Partners, Inc.
- $2.76 Billion
- Q4 2024
A detailed history of Avantax Planning Partners, Inc. transactions in Hcw Biologics Inc. stock. As of the latest transaction made, Avantax Planning Partners, Inc. holds 279,541 shares of HCWB stock, worth $1.97 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
279,541
Previous 279,541
-0.0%
Holding current value
$1.97 Million
Previous $150,000
20.0%
% of portfolio
0.0%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding HCWB
# of Institutions
19Shares Held
3.13MCall Options Held
0Put Options Held
0-
Armistice Capital, LLC New York, NY2.02MShares$14.3 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA182KShares$1.28 Million0.0% of portfolio
-
High Tower Advisors, LLC Chicago, IL181KShares$1.27 Million0.0% of portfolio
-
Cresset Asset Management, LLC Chicago, IL132KShares$930,5290.0% of portfolio
-
Pullen Investment Management, LLC Bradenton, FL75.1KShares$529,5670.01% of portfolio
About HCW Biologics Inc.
- Ticker HCWB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,833,100
- Market Cap $253M
- Description
- HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal...